Gene Page: SLC6A13
Summary ?
GeneID | 6540 |
Symbol | SLC6A13 |
Synonyms | GAT-2|GAT2|GAT3 |
Description | solute carrier family 6 member 13 |
Reference | MIM:615097|HGNC:HGNC:11046|Ensembl:ENSG00000010379|HPRD:10239|Vega:OTTHUMG00000168053 |
Gene type | protein-coding |
Map location | 12p13.3 |
Pascal p-value | 0.811 |
Sherlock p-value | 0.936 |
Fetal beta | -0.22 |
eGene | Myers' cis & trans |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
PMID:cooccur | High-throughput literature-search | Systematic search in PubMed for genes co-occurring with SCZ keywords. A total of 3027 genes were included. | |
Literature | High-throughput literature-search | Co-occurance with Schizophrenia keywords: schizophrenia,schizophrenias | Click to show details |
GO_Annotation | Mapping neuro-related keywords to Gene Ontology annotations | Hits with neuro-related keywords: 2 |
Section I. Genetics and epigenetics annotation
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs4654497 | chr1 | 4224557 | SLC6A13 | 6540 | 0.12 | trans | ||
rs2976809 | chr3 | 125451738 | SLC6A13 | 6540 | 0.13 | trans | ||
rs3110902 | chr7 | 65375101 | SLC6A13 | 6540 | 0.14 | trans | ||
rs4725560 | chr7 | 139640566 | SLC6A13 | 6540 | 0.15 | trans | ||
rs680372 | chr8 | 36999626 | SLC6A13 | 6540 | 0.16 | trans | ||
rs7041951 | chr9 | 20275353 | SLC6A13 | 6540 | 0.07 | trans | ||
rs10733768 | chr10 | 52667246 | SLC6A13 | 6540 | 0.17 | trans | ||
rs11016704 | chr10 | 128989145 | SLC6A13 | 6540 | 0.03 | trans | ||
rs481843 | chr11 | 116525866 | SLC6A13 | 6540 | 0.06 | trans | ||
rs6589566 | chr11 | 116652422 | SLC6A13 | 6540 | 0.01 | trans | ||
rs9529974 | chr13 | 72821935 | SLC6A13 | 6540 | 0.1 | trans | ||
rs17540750 | chr17 | 75205144 | SLC6A13 | 6540 | 0.05 | trans | ||
rs6095741 | chr20 | 48666589 | SLC6A13 | 6540 | 0.03 | trans | ||
rs17255719 | chrX | 12144766 | SLC6A13 | 6540 | 0.13 | trans | ||
rs5991662 | chrX | 43335796 | SLC6A13 | 6540 | 0.1 | trans | ||
rs12556892 | chrX | 93417735 | SLC6A13 | 6540 | 0.17 | trans | ||
rs808754 | chrX | 93438033 | SLC6A13 | 6540 | 0.17 | trans | ||
rs6529399 | chrX | 128763582 | SLC6A13 | 6540 | 0.03 | trans | ||
rs3761581 | chrX | 128789720 | SLC6A13 | 6540 | 0.01 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
PTOV1 | 0.93 | 0.86 |
TSEN34 | 0.93 | 0.89 |
WDR34 | 0.93 | 0.89 |
PPP4C | 0.92 | 0.85 |
RALY | 0.92 | 0.85 |
PYCR1 | 0.92 | 0.87 |
WRAP53 | 0.92 | 0.82 |
NT5DC2 | 0.92 | 0.88 |
DDAH2 | 0.91 | 0.88 |
MARCKSL1 | 0.91 | 0.89 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
C5orf53 | -0.69 | -0.71 |
AF347015.27 | -0.66 | -0.74 |
AF347015.31 | -0.64 | -0.73 |
CA4 | -0.64 | -0.68 |
MT-CO2 | -0.63 | -0.73 |
HLA-F | -0.63 | -0.61 |
AF347015.33 | -0.63 | -0.72 |
MT-CYB | -0.62 | -0.72 |
CCNI2 | -0.62 | -0.63 |
PLA2G4A | -0.61 | -0.68 |
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0005328 | neurotransmitter:sodium symporter activity | IEA | Neurotransmitter (GO term level: 9) | - |
GO:0015293 | symporter activity | IEA | - | |
Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0006836 | neurotransmitter transport | IEA | neuron, Neurotransmitter (GO term level: 5) | - |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0016020 | membrane | IEA | - | |
GO:0005887 | integral to plasma membrane | IEA | - |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
ST WNT CA2 CYCLIC GMP PATHWAY | 20 | 14 | All SZGR 2.0 genes in this pathway |
SENGUPTA NASOPHARYNGEAL CARCINOMA WITH LMP1 DN | 175 | 82 | All SZGR 2.0 genes in this pathway |
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D UP | 157 | 91 | All SZGR 2.0 genes in this pathway |
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP | 194 | 122 | All SZGR 2.0 genes in this pathway |
RODRIGUES THYROID CARCINOMA ANAPLASTIC DN | 537 | 339 | All SZGR 2.0 genes in this pathway |
PATIL LIVER CANCER | 747 | 453 | All SZGR 2.0 genes in this pathway |
SHEN SMARCA2 TARGETS DN | 357 | 212 | All SZGR 2.0 genes in this pathway |
SHEPARD BMYB MORPHOLINO DN | 200 | 112 | All SZGR 2.0 genes in this pathway |
MOREAUX MULTIPLE MYELOMA BY TACI UP | 412 | 249 | All SZGR 2.0 genes in this pathway |
SU KIDNEY | 15 | 8 | All SZGR 2.0 genes in this pathway |
ZAMORA NOS2 TARGETS DN | 96 | 71 | All SZGR 2.0 genes in this pathway |
YOSHIMURA MAPK8 TARGETS UP | 1305 | 895 | All SZGR 2.0 genes in this pathway |
SHEDDEN LUNG CANCER GOOD SURVIVAL A12 | 317 | 177 | All SZGR 2.0 genes in this pathway |
MIKKELSEN MCV6 LCP WITH H3K27ME3 | 29 | 11 | All SZGR 2.0 genes in this pathway |
TORCHIA TARGETS OF EWSR1 FLI1 FUSION TOP20 DN | 18 | 12 | All SZGR 2.0 genes in this pathway |
TORCHIA TARGETS OF EWSR1 FLI1 FUSION DN | 321 | 200 | All SZGR 2.0 genes in this pathway |
FOSTER KDM1A TARGETS UP | 266 | 142 | All SZGR 2.0 genes in this pathway |